Liliana Håversen

1.3k total citations
29 papers, 1.0k citations indexed

About

Liliana Håversen is a scholar working on Nutrition and Dietetics, Molecular Biology and Surgery. According to data from OpenAlex, Liliana Håversen has authored 29 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Nutrition and Dietetics, 9 papers in Molecular Biology and 8 papers in Surgery. Recurrent topics in Liliana Håversen's work include Infant Nutrition and Health (8 papers), Liver Disease Diagnosis and Treatment (4 papers) and Cellular transport and secretion (3 papers). Liliana Håversen is often cited by papers focused on Infant Nutrition and Health (8 papers), Liver Disease Diagnosis and Treatment (4 papers) and Cellular transport and secretion (3 papers). Liliana Håversen collaborates with scholars based in Sweden, United Kingdom and Romania. Liliana Håversen's co-authors include Inger Mattsby‐Baltzer, Lars Hanson, Mirjana Hahn‐Zoric, Bertil G. Ohlsson, Olov Wiklund, Linda Fogelstrand, Lars Baltzer, Gunnar T. Dolphin, Lars Å. Hanson and I Engberg and has published in prestigious journals such as PLoS ONE, Chemical Communications and Scientific Reports.

In The Last Decade

Liliana Håversen

27 papers receiving 997 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liliana Håversen Sweden 14 446 297 242 205 150 29 1.0k
Chih‐Ching Yen Taiwan 21 328 0.7× 423 1.4× 155 0.6× 107 0.5× 128 0.9× 56 1.1k
Susana Aideé González‐Chávez Mexico 11 363 0.8× 370 1.2× 102 0.4× 161 0.8× 112 0.7× 37 1.2k
Thad W. Vickery United States 11 382 0.9× 407 1.4× 313 1.3× 485 2.4× 303 2.0× 17 1.5k
Yan Cao China 21 136 0.3× 539 1.8× 145 0.6× 183 0.9× 106 0.7× 58 1.2k
Robert D. Fusunyan United States 12 468 1.0× 276 0.9× 113 0.5× 303 1.5× 269 1.8× 14 1.1k
Adrianus C. J. M. de Bruijn Netherlands 11 249 0.6× 823 2.8× 178 0.7× 332 1.6× 351 2.3× 13 1.6k
Károly Mészáros United States 19 173 0.4× 298 1.0× 272 1.1× 373 1.8× 110 0.7× 35 1.2k
Serge Dionne Canada 17 237 0.5× 285 1.0× 252 1.0× 244 1.2× 143 1.0× 28 1.1k
Jacek Michałkiewicz Poland 20 181 0.4× 268 0.9× 121 0.5× 265 1.3× 185 1.2× 74 1.1k
Hugo Díaz Canada 9 295 0.7× 814 2.7× 136 0.6× 106 0.5× 194 1.3× 11 1.3k

Countries citing papers authored by Liliana Håversen

Since Specialization
Citations

This map shows the geographic impact of Liliana Håversen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liliana Håversen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liliana Håversen more than expected).

Fields of papers citing papers by Liliana Håversen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liliana Håversen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liliana Håversen. The network helps show where Liliana Håversen may publish in the future.

Co-authorship network of co-authors of Liliana Håversen

This figure shows the co-authorship network connecting the top 25 collaborators of Liliana Håversen. A scholar is included among the top collaborators of Liliana Håversen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liliana Håversen. Liliana Håversen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Håversen, Liliana, et al.. (2025). Fluorescent binding assay for allosteric ligands of liver pyruvate kinase. European Journal of Medicinal Chemistry. 298. 117989–117989.
2.
3.
Battisti, Umberto Maria, Liliana Håversen, Woonghee Kim, et al.. (2024). Sulfone-based human liver pyruvate kinase inhibitors – Design, synthesis and in vitro bioactivity. European Journal of Medicinal Chemistry. 269. 116306–116306. 4 indexed citations
4.
Battisti, Umberto Maria, Leticia Monjas, Liliana Håversen, et al.. (2023). Exploration of Novel Urolithin C Derivatives as Non-Competitive Inhibitors of Liver Pyruvate Kinase. Pharmaceuticals. 16(5). 668–668. 10 indexed citations
5.
Håversen, Liliana, Aleksei Lulla, Chunxia Gao, et al.. (2022). Anthraquinone derivatives as ADP-competitive inhibitors of liver pyruvate kinase. European Journal of Medicinal Chemistry. 234. 114270–114270. 14 indexed citations
6.
Xu, Yongjin, Chunxia Gao, Liliana Håversen, et al.. (2022). Design and development of photoswitchable DFG-Out RET kinase inhibitors. European Journal of Medicinal Chemistry. 234. 114226–114226. 11 indexed citations
7.
Xu, Yongjin, Chunxia Gao, Liliana Håversen, et al.. (2021). Design and development of a photoswitchable DFG-out kinase inhibitor. Chemical Communications. 57(78). 10043–10046. 14 indexed citations
8.
Ekstrand, Matias, Murali K. Akula, Matteo Pedrelli, et al.. (2020). Lack of RAC1 in macrophages protects against atherosclerosis. PLoS ONE. 15(9). e0239284–e0239284. 17 indexed citations
9.
Håversen, Liliana, Adil Mardinoğlu, Mikael Rutberg, et al.. (2018). Vimentin deficiency in macrophages induces increased oxidative stress and vascular inflammation but attenuates atherosclerosis in mice. Scientific Reports. 8(1). 16973–16973. 45 indexed citations
10.
Håversen, Liliana, Moutusi Manna, Mikael Rutberg, et al.. (2018). Glucosylceramide modifies the LPS-induced inflammatory response in macrophages and the orientation of the LPS/TLR4 complex in silico. Scientific Reports. 8(1). 13600–13600. 32 indexed citations
11.
Håversen, Liliana, Reza Mobini, Linda Andersson, et al.. (2016). ARAP2 promotes GLUT1-mediated basal glucose uptake through regulation of sphingolipid metabolism. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1861(11). 1643–1651. 13 indexed citations
12.
Li, Lu, Marcus Ståhlman, Mikael Rutberg, et al.. (2013). ARF6 Regulates Neuron Differentiation through Glucosylceramide Synthase. PLoS ONE. 8(3). e60118–e60118. 4 indexed citations
13.
Li, Lu, Bo Liu, Liliana Håversen, et al.. (2012). The Importance of GLUT3 for De Novo Lipogenesis in Hypoxia-Induced Lipid Loading of Human Macrophages. PLoS ONE. 7(8). e42360–e42360. 17 indexed citations
14.
Olofsson, Sven‐Olof, Linda Andersson, Liliana Håversen, et al.. (2011). The formation of lipid droplets: possible role in the development of insulin resistance/type 2 diabetes. Prostaglandins Leukotrienes and Essential Fatty Acids. 85(5). 215–218. 16 indexed citations
15.
Håversen, Liliana, et al.. (2008). Induction of proinflammatory cytokines by long-chain saturated fatty acids in human macrophages. Atherosclerosis. 202(2). 382–393. 198 indexed citations
16.
Hanson, Lars, et al.. (2008). Immune Function. Advances in experimental medicine and biology. 639. 97–111. 1 indexed citations
17.
Hanson, Lars, Shakila Zaman, Liliana Håversen, et al.. (2008). Growth and Nutrition: The First Six Months. PubMed. 61. 123–134. 1 indexed citations
18.
Wiklund, Olov, et al.. (2007). How can we prevent cardiovascular disease in diabetes. Journal of Internal Medicine. 262(2). 199–207. 10 indexed citations
19.
Håversen, Liliana, Lars Baltzer, Gunnar T. Dolphin, Lars Å. Hanson, & Inger Mattsby‐Baltzer. (2003). Anti‐Inflammatory Activities of Human Lactoferrin in Acute Dextran Sulphate‐Induced Colitis in Mice. Scandinavian Journal of Immunology. 57(1). 2–10. 70 indexed citations
20.
Håversen, Liliana, Bertil G. Ohlsson, Mirjana Hahn‐Zoric, Lars Hanson, & Inger Mattsby‐Baltzer. (2002). Lactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-κB. Cellular Immunology. 220(2). 83–95. 291 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026